Sadaf Durre
Conservative Dentistry, College of Dentistry, Qassim University, Buraydah, SAU.
Cureus. 2020 Jan 23;12(1):e6747. doi: 10.7759/cureus.6747.
Vital pulp therapies have been used in primary teeth and immature permanent teeth. However, with the advent of new bioactive material, the paradigm is shifting toward permanent teeth with mature apices of roots. There are many prospective and retrospective studies, randomized controlled trials, and systematic reviews that report coronal pulpotomy with bioactive material in permanent teeth with pulpal pathosis proved to be as successful as root canal therapy (RCT). Coronal pulpotomy is cost-effective, not very technical demanding like root canal therapy and less time consuming for both the dentists and patients. This treatment can be offered to the patient as an alternative to endodontic therapy. The objective of this study is to review the literature related to the clinical outcome of coronal pulpotomy in permanent teeth with mature apex and having pulpal pathosis. This evidence-based review will facilitate clinical decision making in situations to choose coronal pulpotomy over root canal therapy in mature permanent teeth with irreversible pulpitis.
活髓治疗已应用于乳牙和年轻恒牙。然而，随着新型生物活性材料的出现，治疗模式正在转向牙根根尖已发育成熟的恒牙。有许多前瞻性和回顾性研究、随机对照试验以及系统评价报告称，在患有牙髓病变的恒牙中，使用生物活性材料进行冠髓切断术与根管治疗（RCT）一样成功。冠髓切断术具有成本效益，不像根管治疗那样对技术要求很高，并且对牙医和患者来说耗时都更少。这种治疗方法可以作为牙髓治疗的替代方案提供给患者。本研究的目的是回顾与根尖发育成熟且患有牙髓病变的恒牙冠髓切断术临床结果相关的文献。这一基于证据的综述将有助于在患有不可逆性牙髓炎的成熟恒牙中，在选择冠髓切断术而非根管治疗的情况下进行临床决策。
